
Quarterly report 2023-Q2
added 08-02-2023
Conformis Market Cap 2011-2025 | CFMS
As of December 26, 2025 Conformis has a market cap of $ 16.4 M
Capitalization is the market value of a company whose shares are traded on the stock exchange. It is calculated by multiplying the market price of a share by the total number of the company's shares. Capitalization indicates volatility, risk, and growth potential. This metric is often used for a quick assessment of a company’s investment profile.[1]
Capitalization is an important indicator for investors and analysts, as it helps determine the size and significance of a company in the stock market. Companies with large capitalization are considered more stable and reliable, as they have more resources and financial power to grow and survive in the market.
This metric can be divided into several categories: small (from 300 million to 2 billion dollars), medium (from 2 to 10 billion dollars), and large (over 10 billion dollars). Companies with different levels of capitalization have their own characteristics and risks, so investors usually take this indicator into account when making investment decisions.
Capitalization can also change over time depending on the share price and the number of shares in circulation. Therefore, it is a dynamic indicator that requires constant monitoring and analysis to make well-informed investment decisions.
Annual Market Cap Conformis
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 12.6 M | 4.28 M | 74.1 M | 63.9 M | 32.4 M | 63.3 M | 340 M | 242 M | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 340 M | 4.28 M | 104 M |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.
Market Cap of other stocks in the Medical devices industry
| Issuer | Market Cap | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Abiomed
ABMD
|
16.2 M | - | - | $ 17.2 B | ||
|
Acutus Medical
AFIB
|
5.24 M | - | -26.83 % | $ 2.62 M | ||
|
Allied Healthcare Products
AHPI
|
4.01 M | - | 3.58 % | $ 2.21 M | ||
|
Boston Scientific Corporation
BSX
|
155 B | $ 96.13 | 0.04 % | $ 141 B | ||
|
GenMark Diagnostics, Inc.
GNMK
|
933 M | - | - | $ 1.77 B | ||
|
Lianluo Smart Limited
LLIT
|
147 M | - | 24.59 % | $ 44.8 M | ||
|
Cardiovascular Systems
CSII
|
588 M | - | 0.15 % | $ 844 M | ||
|
Apyx Medical Corporation
APYX
|
45.7 M | $ 3.6 | - | $ 125 M | ||
|
Obalon Therapeutics, Inc.
OBLN
|
35 M | - | -5.86 % | $ 30.6 M | ||
|
Cutera
CUTR
|
46.5 M | - | -10.19 % | $ 1.99 M | ||
|
Bio-Rad Laboratories
BIO
|
7.81 B | $ 301.75 | 0.24 % | $ 8.51 B | ||
|
Apollo Endosurgery
APEN
|
403 M | - | - | $ 475 M | ||
|
Eargo
EAR
|
17 M | - | - | $ 10.2 M | ||
|
BioSig Technologies
BSGM
|
7.3 M | - | 37.08 % | $ 85.7 M | ||
|
Bruker Corporation
BRKR
|
6.9 K | $ 48.12 | 0.21 % | $ 7.17 K | ||
|
Abbott Laboratories
ABT
|
235 B | $ 124.81 | 0.22 % | $ 217 B | ||
|
CryoLife, Inc.
CRY
|
906 M | - | -4.14 % | $ 702 M | ||
|
EDAP TMS S.A.
EDAP
|
60 M | $ 2.97 | 4.58 % | $ 111 M | ||
|
CHF Solutions, Inc.
CHFS
|
1.05 M | - | 1.15 % | $ 34.5 M | ||
|
Soliton, Inc.
SOLY
|
229 M | - | -1.42 % | $ 435 M | ||
|
InMode Ltd.
INMD
|
1.43 B | $ 14.47 | 0.7 % | $ 1.15 B | ||
|
Hancock Jaffe Laboratories, Inc.
HJLI
|
7.99 M | - | -1.98 % | $ 98.3 M | ||
|
Itamar Medical Ltd.
ITMR
|
339 M | - | 0.03 % | $ 1.58 B | ||
|
IRIDEX Corporation
IRIX
|
48.1 M | $ 1.14 | 3.64 % | $ 18.4 M | ||
|
Misonix, Inc.
MSON
|
185 M | - | - | $ 462 M | ||
|
Neovasc
NVCN
|
677 M | - | - | $ 111 M | ||
|
IRadimed Corporation
IRMD
|
670 M | $ 97.06 | 0.48 % | $ 1.23 B | ||
|
Dynatronics Corporation
DYNT
|
1.95 M | - | 14.99 % | $ 929 K | ||
|
Intersect ENT, Inc.
XENT
|
735 M | - | - | $ 955 M | ||
|
LivaNova PLC
LIVN
|
2.28 B | $ 63.08 | -0.27 % | $ 3.42 B | ||
|
LENSAR
LNSR
|
130 M | $ 12.01 | -0.08 % | $ 138 M | ||
|
Medigus Ltd.
MDGS
|
135 M | - | 10.28 % | $ 55.5 M | ||
|
Cognyte Software Ltd.
CGNT
|
661 M | $ 9.54 | - | $ 685 M | ||
|
Second Sight Medical Products
EYES
|
225 K | - | -0.97 % | $ 54.4 M | ||
|
Align Technology
ALGN
|
13.9 B | $ 157.84 | 0.69 % | $ 11.8 B | ||
|
NanoVibronix
NAOV
|
920 K | - | - | $ 1.08 M | ||
|
Accuray Incorporated
ARAY
|
160 M | $ 0.86 | 0.43 % | $ 88.4 M | ||
|
Myomo
MYO
|
5.64 M | $ 1.02 | 12.09 % | $ 7.19 M | ||
|
Avinger
AVGR
|
2.59 M | - | -20.74 % | $ 369 K | ||
|
ClearPoint Neuro
CLPT
|
466 M | $ 14.49 | 0.84 % | $ 392 M | ||
|
FONAR Corporation
FONR
|
85.2 M | $ 14.53 | 0.07 % | $ 95.2 M | ||
|
AxoGen
AXGN
|
859 M | $ 32.64 | -0.61 % | $ 1.44 B | ||
|
Axonics Modulation Technologies
AXNX
|
2.82 B | - | - | $ 3.31 B | ||
|
GBS
GBS
|
2.48 M | - | -0.57 % | $ 7.12 M | ||
|
CONMED Corporation
CNMD
|
1.94 B | $ 40.17 | 1.34 % | $ 1.24 B | ||
|
NuVasive
NUVA
|
2.29 B | - | - | $ 2.07 B | ||
|
OrthoPediatrics Corp.
KIDS
|
589 M | $ 17.41 | 0.75 % | $ 402 M | ||
|
Globus Medical
GMED
|
11.4 B | $ 88.43 | -0.38 % | $ 12 B | ||
|
Integra LifeSciences Holdings Corporation
IART
|
1.88 B | $ 12.66 | 0.56 % | $ 975 M |